These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 11738071)

  • 1. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
    Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
    Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment of ulinastatin and tranexamic acid provides beneficial effects by inhibiting inflammatory and fibrinolytic response in patients undergoing heart valve replacement surgery.
    Chen TT; Jiandong-Liu ; Wang G; Jiang SL; Li LB; Gao CQ
    Heart Surg Forum; 2013 Feb; 16(1):E38-47. PubMed ID: 23439357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass.
    Ray MJ; Marsh NA; Hawson GA
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):679-85. PubMed ID: 7865673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epsilon-aminocaproic acid promotes the release of alpha2-antiplasmin during and after cardiopulmonary bypass.
    Ray MJ; Hales M; Marsh N
    Blood Coagul Fibrinolysis; 2001 Mar; 12(2):129-35. PubMed ID: 11302475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous or discontinuous tranexamic acid effectively inhibits fibrinolysis in children undergoing cardiac surgery with cardiopulmonary bypass.
    Couturier R; Rubatti M; Credico C; Louvain-Quintard V; Anerkian V; Doubine S; Vasse M; Grassin-Delyle S
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):259-65. PubMed ID: 24418941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the in-vivo effect of two tranexamic acid doses on fibrinolysis parameters in adults undergoing valvular cardiac surgery with cardiopulmonary bypass - a pilot investigation.
    Zhou ZF; Zhai W; Yu LN; Sun K; Sun LH; Xing XF; Yan M
    BMC Anesthesiol; 2021 Feb; 21(1):33. PubMed ID: 33530942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM; Kalnoski MH; Frederick M; Chandler WL
    Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased urokinase and consumption of α
    Longstaff C; Locke M
    J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery.
    Páramo JA; Rifón J; Llorens R; Casares J; Paloma MJ; Rocha E
    Haemostasis; 1991; 21(1):58-64. PubMed ID: 1907591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin.
    de Haan J; van Oeveren W
    Thromb Res; 1998 Nov; 92(4):171-9. PubMed ID: 9840026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss.
    Mastroroberto P; Chello M; Zofrea S; Marchese AR
    Eur J Cardiothorac Surg; 1995; 9(3):143-5. PubMed ID: 7540397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo.
    Draxler DF; Zahra S; Goncalves I; Tran H; Hanafi G; Ho H; Keragala CB; Ilich A; Key NS; Myles PS; Medcalf RL
    Blood Coagul Fibrinolysis; 2021 Apr; 32(3):172-179. PubMed ID: 33443933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of retinal detachment surgery on perioperative blood fibrinolysis.
    Malukiewicz-Wiśniewska G; Kotschy M; Kałuzny J
    Curr Eye Res; 1999 Aug; 19(2):123-30. PubMed ID: 10420181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
    Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
    Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
    Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolytic Dysregulation in Total Joint Arthroplasty Patients: Potential Clinical Implications.
    Guler N; Burleson A; Syed D; Banos A; Hopkinson W; Hoppensteadt D; Rees H; Fareed J
    Clin Appl Thromb Hemost; 2016 May; 22(4):372-6. PubMed ID: 26207021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery.
    Slaughter TF; Faghih F; Greenberg CS; Leslie JB; Sladen RN
    Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury.
    Dixon AL; McCully BH; Rick EA; Dewey E; Farrell DH; Morrison LJ; McMullan J; Robinson BRH; Callum J; Tibbs B; Dries DJ; Jui J; Gandhi RR; Garrett JS; Weisfeldt ML; Wade CE; Aufderheide TP; Frascone RJ; Tallon JM; Kannas D; Williams C; Rowell SE; Schreiber MA
    J Trauma Acute Care Surg; 2020 Nov; 89(5):900-907. PubMed ID: 33105308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin.
    Ray MJ; Marsh NA
    Thromb Haemost; 1997 Sep; 78(3):1021-6. PubMed ID: 9308747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.